Folks who want solid protection during the cold and flu season should get the influenza vaccine now, the U.S. Food and Drug ...
The Food and Drug Administration halted Novavax's trial of a combination vaccine for COVID and influenza, as well as a ...
Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...
Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...
The U.S. Food and Drug Administration has put a trial of Novavax’s COVID-influenza and its standalone flu vaccines on hold after a participant who took the combination shot reported nerve damage, the ...
The Food and Drug Administration (FDA) is placing a hold on Novavax's (NVAX) experimental flu-COVID vaccines after a patient ...
However, Novavax's shares recently dropped by about 20% in one day after it announced a clinical setback. The biotech's stock ...
The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 ...
The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.
FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for ...
The FDA has approved AstraZeneca’s FluMist Nasal Spray to be used outside a healthcare setting. “The new FDA release is for ...
The Food and Drug Administration put clinical holds on Novavax's COVID-19 and flu combination vaccine and its standalone flu ...